# Creatine in Treating Patients With Cancer-Associated Weight Loss

> **NCT00081250** · PHASE3 · COMPLETED · sponsor: **Alliance for Clinical Trials in Oncology** · enrollment: 300 (estimated)

## Conditions studied

- Anorexia
- Cachexia
- Unspecified Adult Solid Tumor, Protocol Specific
- Weight Changes

## Interventions

- **DIETARY_SUPPLEMENT:** creatine monohydrate
- **OTHER:** placebo

## Key facts

- **NCT ID:** NCT00081250
- **Lead sponsor:** Alliance for Clinical Trials in Oncology
- **Sponsor class:** OTHER
- **Phase:** PHASE3
- **Study type:** INTERVENTIONAL
- **Status:** COMPLETED
- **Start date:** 2004-12
- **Primary completion:** 2007-12
- **Final completion:** 2017-07
- **Target enrollment:** 300 (ESTIMATED)
- **Last updated:** 2020-04-29

## Collaborators

- [object Object]

## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT00081250

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT00081250, "Creatine in Treating Patients With Cancer-Associated Weight Loss". Retrieved via AI Analytics 2026-07-13 from https://api.ai-analytics.org/clinical/NCT00081250. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*